Insmed Inc. buy Guggenheim
Start price
09.07.24
/
50%
€65.00
Target price
09.07.25
€87.84
Performance (%)
25.38%
End price
10.07.25
€81.50
Summary
This prediction ended on 10.07.25 with a price of €81.50. The BUY prediction by Guggenheim finished with a performance of 25.38%. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 33.738% | 33.738% | 19.375% |
| iShares Core DAX® | 0,18 % | 5,07 % | 8,98 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % | 26,44 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % | 47,89 % |
| iShares S&P 500 | -0,17 % | 0,90 % | 22,97 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $70.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten